Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01698918
Title Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | GBR | FRA | ESP

Facility Status City State Zip Country Details
University of Alabama Comprehensive Cancer Center SC-2 Birmingham Alabama 35294 United States Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
Loma Linda University Loma Linda Loma Linda California 92354 United States Details
Breastlink Medical Group Dept. of BreastlinkResearchGrp Long Beach California 90806 United States Details
Oncology Specialists, SC Advocate Medical Group-Niles Park Ridge Illinois 60068-0736 United States Details
St. Francis Health Comprehensive Cancer Center Topeka Kansas 66606-169 United States Details
Norton Healthcare Inc SC Louisville Kentucky 40202 United States Details
Baystate Medical Center SC-2 Springfield Massachusetts 01199 United States Details
Saint Barnabas Medical Center CancerCenter of Saint Barnabas Livingston New Jersey 07039 United States Details
University of New Mexico Hospital SC Albuquerque New Mexico 87106 United States Details
Broome Oncology SC Johnson City New York 13790 United States Details
Columbia University Medical Center- New York Presbyterian Columbia New York New York 10032 United States Details
Cone Health Cancer Center Greensboro North Carolina 27403 United States Details
East Texas Hematology Clinic SC Lufkin Texas 75904 United States Details
Utah Cancer Specialists Dept.of Utah Cancer Spec. (3) Salt Lake City Utah 84106 United States Details
Novartis Investigative Site Santa Rosa La Pampa 6300 Argentina Details
Novartis Investigative Site Rosario Santa Fe S2000KZE Argentina Details
Novartis Investigative Site Porto Alegre RS 90035-003 Brazil Details
Novartis Investigative Site Sao Paulo SP 01317-002 Brazil Details
Novartis Investigative Site Sao Paulo SP 04014-002 Brazil Details
Novartis Investigative Site Besancon cedex 25030 France Details
Novartis Investigative Site Bordeaux 33076 France Details
Novartis Investigative Site Hyères 83400 France Details
Novartis Investigative Site Le Chesnay 78157 France Details
Novartis Investigative Site Lyon 69373 France Details
Novartis Investigative Site Nancy 54000 France Details
Novartis Investigative Site Nantes Cedex 44277 France Details
Novartis Investigative Site Kecskemet Bacs Kiskun 6000 Hungary Details
Novartis Investigative Site Gyula 5700 Hungary Details
Novartis Investigative Site Szekszard 7100 Hungary Details
Novartis Investigative Site Nagoya-city Aichi 467-8602 Japan Details
Novartis Investigative Site Sapporo-city Hokkaido 003-0804 Japan Details
Novartis Investigative Site Shiwa-gun Iwate 028-3695 Japan Details
Novartis Investigative Site Kawasaki-city Kanagawa 216-8511 Japan Details
Novartis Investigative Site Kumamoto City Kumamoto 860-8556 Japan Details
Novartis Investigative Site Seoul 01812 Korea, Republic of Details
Novartis Investigative Site Seoul 06273 Korea, Republic of Details
Novartis Investigative Site Seoul 06351 Korea, Republic of Details
Novartis Investigative Site Maastricht AZ 5800 Netherlands Details
Novartis Investigative Site Lisboa 1400-038 Portugal Details
Novartis Investigative Site Lisboa 1649-035 Portugal Details
Novartis Investigative Site Porto 4200-072 Portugal Details
Novartis Investigative Site Salamanca Castilla Y Leon 37007 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46010 Spain Details
Novartis Investigative Site La Coruna Galicia 15006 Spain Details
Novartis Investigative Site Bangkok 10330 Thailand Details
Novartis Investigative Site Bangkok 10400 Thailand Details
Novartis Investigative Site Bangkok 10700 Thailand Details
Novartis Investigative Site Antalya 07059 Turkey Details
Novartis Investigative Site Istanbul 34303 Turkey Details
Novartis Investigative Site Izmir 35040 Turkey Details
Novartis Investigative Site Bath BA1 3NG United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field